In 2024, startups saw a notable resurgence in large-scale funding rounds. By May, over 100 startups had secured funding ...

Lipid nanoparticle-mediated mRNA delivery to CD34 + cells in rhesus monkeys 的研究论文。 该研究开发了一种名为LNP 67 的脂质纳米颗粒（LNP），无需骨髓动员或化疗预 ...

Genome editing with CRISPR, a technology that allows precise modification of genetic material, is transforming the field of microalgal biotechnology. It is opening up new possibilities for their ...

Proliferative vitreoretinopathy (PVR) is an eye condition that leads to blindness and can currently only be addressed with surgery. A team led by research hospital Massachusetts Eye and Ear and ...

School of Biomedical Engineering, University of British Columbia, Vancouver V6T 1Z3, Canada Michael Smith Laboratories, University of British Columbia, Vancouver V6T 1Z4, Canada School of Biomedical ...

The analyst notes that Editas announced a shift in focus toward in vivo development, specifically working on lipid nanoparticle (LNP) formulations for treating sickle cell disease (SCD ...

which are essential components of lipid nanoparticles (LNPs), the molecules that underlie the COVID-19 vaccines and other cutting-edge treatments, to enhance mRNA delivery. The study was published in ...

Satchi-Fainaro said the researchers did not rely on full protein expression via mRNA, unlike the Moderna and Pfizer Covid vaccines. “Instead, using our computational bioinformatics tools, we ...

Additionally, the review explores the integration of mRNA vaccines with other immunotherapies and the utilization of progressive delivery platforms, such as lipid nanoparticles, to improve immune ...